Featured Research

from universities, journals, and other organizations

Could A Popular HIV Drug Benefit Hepatitis B Patients?

Date:
May 4, 2006
Source:
Saint Louis University
Summary:
Saint Louis University School of Medicine researchers are studying the effectiveness of a drug for patients with chronic hepatitis B that is currently used to treat HIV.

Saint Louis University School of Medicine researchers are studying the effectiveness of a drug for patients with chronic hepatitis B that is currently used to treat HIV.

Hepatitis B patients currently take an antiviral called Hepsera, says Adrian Di Bisceglie, M.D., chief of hepatology at Saint Louis University School of Medicine. The drug under investigation in the study, called Tenofovir, is similar to Hepsera in that it is a “nucleotide analog” that helps stop the virus from propagating. Researchers will study Tenofovir’s efficacy compared to Hepsera’s in up to 300 patients worldwide.

“We have high hopes that Tenofovir will be more potent than the current drug regimen for hepatitis B patients,” Di Bisceglie says.

Hepatitis B is a disease passed down from mother to infant during pregnancy and has reached epidemic levels in China, Vietnam and sub-Saharan Africa.

“It is a terrible disease because it kills people in their prime of their lives – in their 30s, 40s and 50s,” Di Bisceglie says. “What makes it even more devastating is that there are mild non-specific symptoms or sometimes no symptoms at all.”

Most American women who undergo prenatal screening are also screened for hepatitis B, Di Bisceglie says, and because there is a safe, effective vaccine, hepatitis B is a “controllable” disease.

“But we hope this new antiviral can help improve the lives of patients with hepatitis B,” he says.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. degree west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others. The School of Medicine trains physicians and biomedical scientists, conducts medical research, and provides health services on a local, national and international level.


Story Source:

The above story is based on materials provided by Saint Louis University. Note: Materials may be edited for content and length.


Cite This Page:

Saint Louis University. "Could A Popular HIV Drug Benefit Hepatitis B Patients?." ScienceDaily. ScienceDaily, 4 May 2006. <www.sciencedaily.com/releases/2006/05/060504075005.htm>.
Saint Louis University. (2006, May 4). Could A Popular HIV Drug Benefit Hepatitis B Patients?. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2006/05/060504075005.htm
Saint Louis University. "Could A Popular HIV Drug Benefit Hepatitis B Patients?." ScienceDaily. www.sciencedaily.com/releases/2006/05/060504075005.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins